Jabra Enhance Select 700 vs MDHearing Volt

The Jabra Enhance Select 700 is a premium-priced OTC hearing aid available at $1,795, earning a B grade with a SoundScore of 3.8/5 in our lab testing. This behind-the-ear device ranks #26 of 65 OTC hearing aids tested, placing it in the top 38% of the category. In our testing, the Enhance Select 700 showed notable strengths in comfort-related metrics. Own-voice comfort scored a solid 3.7/5, measuring 1.19 points above the category average—a meaningful advantage for wearers sensitive to the sound of their own voice. Feedback handling was excellent at 5.0/5, well above the 4.54 category average, indicating reliable stability during typical wear. Speech performance presented a mixed picture. Speech in quiet scored a solid 3.1/5, sitting 0.27 points above average. However, speech in noise was a weakness at 1.0/5, falling 0.48 points below the category average—an important consideration if challenging listening environments are a priority. Music streaming scored 2.5/5, which is above the category average by 0.58 points but only mixed in absolute terms. At this price point, several alternatives delivered stronger overall performance in our testing, including the Lucid Tala (4.61/5) and Audicus Omni 2 (4.59/5). The Jabra Enhance Select 300 and Lucid Engage also achieved higher scores at lower prices. The Enhance Select 700 may suit those prioritizing own-voice comfort and feedback stability over speech-in-noise performance, but shoppers should weigh these trade-offs carefully given the premium pricing.

The MDHearing Volt is a budget-priced prescription hearing aid released in 2020, earning a B grade with a SoundScore of 3.0/5 in our lab testing. At $397, it sits in the lowest price tier for prescription devices, ranking #34 of 39 in its category. In our testing, the Volt showed a mixed performance profile with one standout strength: feedback handling scored an excellent 5.0/5, which is 0.28 points above the category average. This means users can expect minimal whistling or squealing during typical wear. However, speech performance was limited, with speech in quiet scoring 1.8/5 (1.65 points below average) and speech in noise at 1.0/5 (1.11 points below average). Own voice comfort was mixed at 2.6/5, roughly matching the category average. Music streaming capability was not functional in our testing, scoring 0.0/5—a significant limitation for users who want to stream audio from their phone. This is 2.76 points below the prescription hearing aid category average. The Volt may appeal to budget-conscious consumers who prioritize basic amplification and feedback-free wear over advanced speech enhancement or streaming features. Those seeking stronger speech performance in the same price range may want to consider alternatives like the RxEars Rxi, which scored 4.07/5 in our testing. The Volt's rechargeable battery and behind-the-ear design offer practical convenience, but its core sound performance reflects its entry-level positioning.